attempts to define and to elucidate the incidence of essential hypertension in pregnancy, because the highest levels of the normal arterial bloodpressure in pregnant women have not yet been determined. Blood-pressure It makes matters very complicated, however, for hypertension to be diagnosed above different levels in pregnant women of different ages, so for convenience of discussion and assessment of results it would be advisable to agree upon an upper limit of normal blood pressure for pregnant women of all ages. When this figure has been determined we can then define essential hypertension in pregnancy as a condition in which it is exceeded in the absence of any known cause. Pickering (1955) considers that any dividing line between a normal and a high blood pressure is artificial and that hypertensive patients are merely the tail end of a skewed Gaussian curve of distribution. However, Platt (1959) , from a study of bimodal blood-pressure curves In normal pregnancy the blood-pressure falls during the second trimester, as was first shown by Hare and Karn in I929. This may be due to the loss of tone of the smooth muscle throughout the body as a consequence of the increased production of progesterone. Duff (1958) considers it results from the increased output of (estrogens occurring at this time, whilst Burwell (1938) thinks it is due to the arterio-venous shunt effect of the placental circulation. The fall is similarly seen in cases of essential hypertension, as was first described by Reed and Teel (1938) Browne (1958) found it to occur in 35.5%, whilst Gate (I960) had an incidence of 57%. Morris (1958) If the blood-pressure reaches I50/90 when she is first seen, or if it rises to this figure later in pregnancy but before the ftetus is mature, she should be treated by hypotensive drugs. There are many of these drugs now available, of which guanethidine sulphate (Ismelin) can be recommended. This is not a ganglion-blocking agent, but instead selectively inhibits the peripheral sympathetic system. The patient should remain in hospital while the correct dosage is decided upon. Thus she may be given io mg. daily by mouth increasing by io mg. every four days until the optimum controlling dose is determined and she is stabilised with a pressure at normal levels on standing; the dosage can be guided simply by the response of the hypertension and there is no risk of paralytic ileus or constipation. The patient should then be discharged, subsequently to be seen weekly at the clinic, when the dosage may be altered or the patient readmitted as appears necessary. Sedation such as phenobarbitone 1 gr. twice daily may also be given.
If the pressure rises persistently above 6o/oo00 the patient should be kept in hospital and given complete rest in bed while the hypotensive therapy is continued. There are now additional hazards to be guarded against. Firstly steps must be taken to avoid foetal death if possible, by increasing the placental circulation. It was shown by Morris, Osborne and Payling Wright (1956) 
